Commentary

Podcast

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

Although it has some daunting adverse effects, Glenn Short, PhD, said ibogaine offers unique biological and therapeutic effects.

This month, we spoke with Glenn Short, PhD, senior vice president of Early Development at atai Life Sciences, about an under-discussed psychedelic drug: ibogaine. Although it has some daunting adverse effects, Short said ibogaine offers unique biological and therapeutic effects.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Lenacapavir | Image Credit: luchschenF | stock.adobe.com
Related Content
Doctor measuring overweight boy in clinic - Image credit: Africa Studio | stock.adobe.com
September 4th 2025

Fitness, Lean Mass Linked to Reduced Anxiety and Depression in Children

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
September 4th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Motor neuron connecting to muscle fiber, 3D illustration
September 4th 2025

Study: Apitegromab Meaningfully Improves Motor Function in Spinal Muscular Atrophy

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
September 4th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Oral metformin tablets (CKD) -- Image credit: Sherry Young | stock.adobe.com
September 4th 2025

Metformin, Potential Treatment for ADPKD, Currently Undergoing Investigation in Long-Term Efficacy Trial

Gillian McGovern, Associate Editor
Skin disorder, pepper appearance from scleroderma, autoimmune disease male hand Skin disorder pepper appearance from vitiligo,scleroderma raynaud, medical concept autoimmune disease.
September 4th 2025

Patients With Systemic Sclerosis Face Decreased HDL-C, Increased Lipoprotein(a)

Luke Halpern, Assistant Editor
© 2025 MJH Life Sciences

All rights reserved.